Judit Nyirady

Judit Nyirady, MD, MBA, currently serves as the Senior Vice President and Global Chief Medical Officer at ALK, where responsibilities include overseeing the Medical Affairs Organization and driving high-performing global medical affairs teams with a focus on patient-centric drug development. Previously, Judit was the Interim Chief Medical Officer at Cara Therapeutics, managing clinical development for Notalgia Paresthetica and engaging with various stakeholders. At LEO Pharma, Judit held multiple vice president roles, significantly enhancing global medical affairs and establishing competencies across 22 affiliates. Judit's extensive experience in medical affairs spans notable positions at Novartis Pharmaceuticals and Johnson & Johnson, where leadership in dermatology and immunology was pivotal. Educational credentials include an MD from the University of Szeged and an MBA from Cornell Johnson Graduate School of Management.